Skip to main content
STAR COMBO PHARMA LIMITED logo

STAR COMBO PHARMA LIMITED — Investor Relations & Filings

Ticker · S66 ISIN · AU0000004798 ASX Manufacturing
Open in API
Filings indexed 195 across all filing types
Latest filing 2019-12-18 Governance Information
Country AU Australia
Listing ASX S66

About STAR COMBO PHARMA LIMITED

https://www.starcombo.com.au

Star Combo Pharma Limited specializes in the development, manufacturing, and distribution of vitamins, dietary supplements, and skincare products. The organization operates Therapeutic Goods Administration (TGA) licensed facilities, offering comprehensive Original Equipment Manufacturing (OEM) and Original Design Manufacturing (ODM) services. Its product portfolio encompasses a wide range of health and beauty solutions marketed under proprietary brands, including Costar, Living Healthy, Amax, and J&K. The company focuses on delivering premium health products to diverse markets, leveraging technical expertise in formulation and large-scale production. By maintaining rigorous quality control standards and providing end-to-end manufacturing solutions, the entity serves as a strategic partner for businesses seeking customized health and wellness products.

Recent filings

Filing Released Lang Actions
Corporate Governance Statement - Amendment 23 pages 407.7KB
Governance Information Classification · 95% confidence The document is a letter from Star Combo Pharma Ltd to the ASX Listings Compliance dated 18 December 2019. It discusses the submission of a revised Appendix 4G and a Corporate Governance Statement (CGS) for the financial year ended 30 June 2019. The Appendix 4G is a key to disclosures related to the ASX Corporate Governance Council Principles and Recommendations. The document includes detailed disclosures about compliance with corporate governance recommendations, explanations for non-compliance, and references to where the full Corporate Governance Statement can be found (a URL). The document is not the full Annual Report but rather a governance-related compliance filing. It is not an announcement of a report publication but contains substantive governance disclosures. The content aligns with the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. Therefore, the appropriate classification is CGR with high confidence.
2019-12-18 English
2019 AGM Chairman and CEO Presentation 18 pages 3.7MB
AGM Information Classification · 100% confidence The document is an ASX announcement dated 26 November 2019, titled 'Star Combo 2019 AGM – Chairman and CEO Presentation'. It contains detailed presentation materials delivered at the Annual General Meeting (AGM) of Star Combo Pharma Limited, including the Chairman's address, CEO presentation, business overview, financial highlights, strategic initiatives, and operational updates. The content is consistent with materials typically shared during an AGM to inform shareholders about company performance and strategy. There is no indication that this is a full annual report, earnings release, or other regulatory filing. The document is not merely an announcement of a report but the actual presentation content. Therefore, the appropriate classification is AGM Information (AGM-R).
2019-11-25 English
2019 AGM Results of Meeting 2 pages 120.4KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 26 November 2019 reporting the results of the Annual General Meeting (AGM) of Star Combo Pharma Ltd. It details the voting outcomes on various resolutions including the adoption of the Remuneration Report, re-election of a director, ratification of share issues, and approval of additional placement capacity. The document includes proxy vote statistics and confirms the resolutions were carried. The content is focused on the official results of shareholder votes at the AGM, which matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length is 4440 characters, which is short but contains substantive voting results, not just a notice or link to a report, so it is not a Report Publication Announcement (RPA). Therefore, the correct classification is DVA with high confidence.
2019-11-25 English
Inature Organic Care acquisition 1 page 67.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 18 November 2019 regarding Star Combo Pharma's acquisition of 51% of Australian Inature Organic Care. It details the acquisition terms, strategic rationale, and business implications. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a corporate announcement about a capital transaction (acquisition) and expansion of business operations. It is not a full annual or interim report, earnings release, or regulatory filing. The content fits best under Capital/Financing Update (CAP) as it relates to company fundraising and capital structure changes through acquisition.
2019-11-17 English
2019 Annual Report to Shareholders 67 pages 6.7MB
Regulatory Filings
2019-10-24 English
S66 App 4G and Corporate Governance Statement 21 pages 294.6KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures. It includes a key to disclosures against the Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2019. The document is a corporate governance statement or an appendix related to corporate governance disclosures, approved by the board and lodged with ASX alongside the annual report. It does not contain financial statements or detailed financial performance data but focuses on governance practices and compliance with ASX corporate governance recommendations. This type of document fits best under the category 'Governance Information (CGR)', which covers reports detailing the company's internal rules, board structure, and governance practices.
2019-10-24 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.